Clinical Research

Widely touted in multiple sclerosis patient communities, low-dose naltrexone does appear to improve disease scores in about half of mice with an experimentally induced version of MS. Researchers found a similar pattern of results with met-enkephalin.

Two teams of researchers found strikingly different degrees of autoimmune response to Kir4.1 inward rectifying potassium channels among multiple sclerosis patients. At first, the reason for the discrepancy wasn’t obvious.

In a head-to-head comparison of four MS models, one based on HSV-1 infection shows its value

Results from this longitudinal clinical study of nearly 100 men with MS concluded that low blood levels of testosterone were associated with increased risk of disability